🇦🇺 Australia Country × Condition
melanoma Clinical Trials in Australia
Active clinical trials for melanoma with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇦🇺 Australia
Active Trials in Australia (5)
NCT06242470 Phase 1
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
Enrollment
250 pts
Country
🇦🇺 Australia
MacroGenics
View Trial → NCT05180942
Recruiting
Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
Enrollment
130 pts
Country
🇦🇺 Australia
Monash University
View Trial → NCT06326411 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Enrollment
230 pts
Country
🇦🇺 Australia
Nested Therapeutics, Inc
View Trial → NCT07339176 Phase 1, Phase 2
Recruiting
Intratumoral N17350 in Advanced Solid Tumors
Enrollment
275 pts
Country
🇦🇺 Australia
Onchilles Pharma Inc
View Trial → NCT06910657 Phase 1
Recruiting
IDOV-Immune for Advanced Solid Tumors
Enrollment
78 pts
Country
🇦🇺 Australia
ViroMissile, Inc.
View Trial → Frequently Asked Questions
How many melanoma clinical trials are active in Australia?
There are currently 5 active clinical trials for melanoma with sites in Australia, of which 5 are actively recruiting patients.
How can I join a melanoma clinical trial in Australia?
To join a melanoma clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are melanoma trials in Australia?
Active melanoma trials in Australia span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology